The QualityStocks Daily Stock List
- Cloud Peak Energy, Inc. (CLDPQ)
- Manganese X Energy Corp. (SNCGF)
- XT Energy Group, Inc. (XTEG)
- Crop Infrastructure Corp. (CRXPF)
- PASSUR Aerospace, Inc. (PSSR)
- Gungnir Resources, Inc. (ASWRF)
- Blue Moon Zinc Corp. (BMOOF)
- Cardax, Inc. (CDXI)
- First Choice Healthcare Solutions, Inc. (FCHS)
- RenovaCare, Inc. (RCAR)
- New Jersey Mining Company (NJMC)
- Nutra Pharma Corp. (NPHC)
- alpha-En Corp. (ALPE)
- Continental Energy Corp. (CPPXF)
Cloud Peak Energy, Inc. (CLDPQ)
Zacks, Investing.com, TipRanks, InvestorsHub, Global Banking and Finance, Stockopedia, OTC Markets, Investors Hangout, and Stockhouse reported on Cloud Peak Energy, Inc. (CLDPQ), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Cloud Peak Energy, Inc. is the only pure-play Powder River Basin coal company. It mines low sulfur, subbituminous coal and also provides logistics supply services. The Company owns and operates three surface coal mines in the Powder River Basin, the lowest cost major coal producing region in the nation. On May 10, 2019, Cloud Peak Energy, Inc., along with its affiliates, filed a “voluntary petition” for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Cloud Peak Energy has its corporate office in Gillette, Wyoming.
The Company is a sustainable fuel supplier for roughly two percent of the nation’s electricity. Cloud Peak Energy has approximately 1,300 employees. Cloud Peak is widely recognized for its exemplary performance in its safety and environmental programs.
The Antelope and Cordero Rojo mines are situated in Wyoming. The Spring Creek Mine is situated in Montana. Cloud Peak Energy sold about 50 million tons last year from its three mines to customers located throughout the United States and internationally. In addition, Cloud Peak owns rights to considerable undeveloped coal and complementary surface assets in the Northern People’s Republic of China, further building the Company’s long-term position to serve Asian export and domestic customers.
This past May, Cloud Peak Energy announced that it received interim approvals from the U.S. Bankruptcy Court for the District of Delaware for all the “First Day” motions related to the voluntary Chapter 11 petitions filed on May 10, 2019.
Mr. Colin Marshall, President and Chief Executive Officer of Cloud Peak Energy, said, “We are pleased to have received interim approval of our First Day motions, which will allow us to continue operating as normal as we continue the sale process for all of Cloud Peak’s assets. As we move through this process, we remain focused on safely and efficiently meeting our customer commitments. I would like to thank our employees, customers and business partners for their continued support.”
Cloud Peak Energy, Inc. (CLDPQ), closed Thursday's trading session at $0.031, off by 16.9457%, on 44,7925 volume with 62 trades. The average volume for the last 3 months is 1,679,174 and the stock's 52-week low/high is $0.029999999/$3.51999998.
Manganese X Energy Corp. (SNCGF)
Ahead of the Herd, Bull Market News, Geology for Investors, Investing News, InvestorIntel, Oil & Gas 360, The Prospector, Mining Stock Education, StreetWise Reports, Stockwatch, Wallet Investor, Stockhouse, 4-Traders, and Market Screener reported earlier on Manganese X Energy Corp. (SNCGF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Manganese X Energy Corp.’s mission is to acquire and advance high potential manganese mining prospects in North America. Its intention is to supply value added materials to the lithium ion battery and other alternative energy industries. The Company previously went by the name Sunset Cove Mining Inc. It changed its corporate name to Manganese X Energy Corp. in December of 2016. Manganese X Energy has its headquarters in Saint-Laurent, Quebec.
Manganese dioxide is a key element in the manufacture of the most promising types of Lithium Ion batteries. These kinds of batteries are the most promising due to their superior storage capacity, safety, as well as cost.
Manganese X Energy’s plan is to provide a secure ethically sourced manganese supply by exploring and developing its manganese rich deposit near Woodstock, New Brunswick (Battery Hill Project). The Battery Hill property comprises 55 claims totaling 1,228 hectares positioned in Carlton County, New Brunswick. The project covers all or part of five manganese zones - Iron Ore Hill, Moody Hill, Sharpe Farm, Wakefield and Maple Hill.
Manganese X Energy also has its Peter Lake Property. Peter Lake comprises 34 claims totalling about 1985 Ha situated in the Mont-Laurier Terrane, in the Central Grenville Province, Quebec. Two Copper-Nickel-Cobalt Occurrences called Peter Lake North and Peter Lake South are included within the Property. Prior grab sampling returned values ranging from 0.4 percent to 22.8 percent copper, 0.14 percent to 0.73 percent nickel, 500 ppm to 0.266 percent cobalt, and also elevated gold and silver.
The Peter Lake Property, roughly 20 kms south of Kintavar Exploration Inc.'s Mitchi Project, is where Kintavar announced significant new copper, silver, and gold mineralization (Kintavar News Release dated August 8, 2018). Manganese X Energy plans to conduct an exploration program on Peter Lake, with a complete compilation of historic geological work, followed by line cutting, ground geophysics, geology/prospecting, trenching and possible diamond drilling in the future. Special attention during the exploration program will be aimed at the cobalt and possible gold-platinum-palladium potential of the Property.
This past April, Manganese X Energy announced that a standalone subsidiary has been created within the parent Company named Disruptive Battery Corp. The Company has secured the domain batterydisruptors.com and its website is now under construction. The new company was formed to hasten a manganese thesis as it relates to fuel cells and stored energy. The intention is to advance the movement of manganese for greener power production and penetrating the EV (Electric Vehicle) market.
Manganese X Energy Corp. (SNCGF), closed Thursday's trading session at $0.0893, even for the day, on 2,200 volume. The average volume for the last 3 months is 491 and the stock's 52-week low/high is $0.065949998/$0.155599996.
XT Energy Group, Inc. (XTEG)
Penny Stock Hub, Zacks, OTC Markets, Wallstreet Online, Investors Hangout, MarketScreener, Last10k, StreetInsider, Stock Target Advisor, Investing.com, WhaleWisdom, GuruFocus, TradingView, Wallet Investor, Simply Wall St, MarketWatch, and YCharts reported previously on XT Energy Group, Inc. (XTEG), and today we report on the Company, here at the QualityStocks Daily Newsletter.
XT Energy Group, Inc. provides renewable energy services. It centers on the development of electricity generation systems, installation of photovoltaic solar panels, as well as related products. XT Energy Group serves customers in the People’s Republic of China (PRC) and in the United States. The Company’s shares trade on the OTC Markets Group’s OTCQB. The Company previously went by the name Xiangtian (USA) Air Power Co., Ltd. It changed its name to XT Energy Group, Inc. in November of last year. Established in 2008 by Deng Rong Zhou, XT Energy Group has its corporate headquarters in Xianning, Hubei Province, China.
XT Energy Group engages in the compressed air energy storage field, chiefly in the PRC. XT Energy offers air compression power generation systems with a photovoltaic (PV) installation for industrial users, including factories and power plants; and PV systems without the air compression generation technology. XT Energy engages in the production of electricity generation systems, which combines the compressed air storage technology with photovoltaic panels of the Company. Furthermore, XT employs proprietary compressed air energy storage power generation technology that can store energy for other alternative energy sources such as using solar, wind, geothermal, and tidal as raw power to regenerate electricity power without the use of fossil fuels or other chemical methods.
In addition, the Company provides air source heat pump systems that transfers heat from outside to inside of a building, or vice versa; PV panels; synthetic fuel and related products, such as fuel additives, engine lubricants, and methanol fuel. XT Energy also provides hydraulic parts consisting of hydraulic cylinders, diesel pumps, motor oil pumps, and hydraulic valves. Moreover, XT Energy designs and manufactures hydraulic pump stations, cylinders, and also high-pressure valves.
In essence, XT Energy Group is a holding company primarily engaged in energy-related businesses. The Company is involved in the installation of power generation systems by way of its subsidiaries and controlled entities.
XT Energy Group, Inc. (XTEG), closed Thursday's trading session at $4.40, up 4.7619%, on 5,910 volume with 11 trades. The average volume for the last 3 months is 9,879 and the stock's 52-week low/high is $3.10999989/$12.00.
Blue Moon Zinc Corp. (BMOOF)
NetworkNewsWire, Small Cap Power, StreetWise Reports, Geology for Investors, StockPulse, Metals News, TradingView, Dividend Investor, MarketScreener, Mining.com, Gold Telegraph, Stockwatch, Wallet Investor, Morningstar, Stockhouse and Junior Mining Network reported earlier on Blue Moon Zinc Corp. (BMOOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Blue Moon Zinc Corp. engages in the exploration and development of mineral resource properties in the USA. At present, it is advancing its 100 percent-controlled Blue Moon zinc deposit that also contains copper, gold and silver. The Company previously went by the name Savant Explorations Ltd. It changed its name to Blue Moon Zinc Corp. in July of 2017. Incorporated in 2007, Blue Moon Zinc is headquartered in Vancouver, British Columbia.
The Company’s advanced stage Blue Moon project is subject to an NI 43-101 Mineral Resource estimate with roughly 7.8 million tons with a grade of 8.07 percent zinc equivalent for about 771 million pounds of zinc, 71 million pounds of copper, 300,000 ounces of gold and 10 million ounces of silver in the Inferred category. The resource is open at depth and along strike and has favorable metallurgy. Blue Moon’s plan is to advance the project to feasibility and permitting.
The Blue Moon Deposit is in east central California within Mariposa County in the Foothills. The property is accessible by gravel roads off nearby paved highway. There are active mines in the area and was part of the original California gold rush.
Blue Moon Zinc also has its Yava Property in the Mackenzie Mining District, Territory of Nunavut, around 450 kilometers northeast of Yellowknife. Yava covers four known base and precious metal occurrences mid-way along the length of this greenstone belt. The Yava mining lease includes 9 km of northwest-trending strike-length along a volcanic-sedimentary rock interface.
Three of the mineral claims at the Yava Property are contiguous with the mining lease. They encompass this strike-length for 2.5 km to the southeast. Five of the mineral claims cover, though not continuously, a 25 km northwest extension of this strike-length. The other eight mineral claims encompass volcanic rocks in the footwall of the volcanic-sedimentary rock interface.
In January of this year, Blue Moon Zinc announced the discovery of high-grade zinc-copper-rich massive sulphides with precious metal values at its Blue Moon VMS deposit in Mariposa County, California. Given the significance of the results, the first drilling at Blue Moon in almost 30 years, a Phase 2 follow-up drill program is planned to begin soon in an attempt to expand the highest-grade zone ever encountered at the deposit.
Mr. Patrick McGrath , Blue Moon Zinc Chief Executive Officer, said, "Drill hole BMZ-78 is a major breakthrough at this zinc-rich VMS deposit, supporting the continuity of the system while also demonstrating the presence of a very high-grade zinc core with impressive copper and precious metal content. Gold values of 4.98 g/t and 5.00 g/t, respectively, over five feet and silver values of 130 g/t over three feet are present within the massive sulphides."
Blue Moon Zinc Corp. (BMOOF), closed Thursday's trading session at $0.0192, up 32.4138%, on 129,000 volume with 10 trades. The average volume for the last 3 months is 7,663 and the stock's 52-week low/high is $0.009999999/$0.079999998.
CROP Infrastructure Corp. (CRXPF)
MicroSmallCap, StreetSignals, Investing News, Marijuana Stock Review, Pot Stock News, Daily Marijuana Observer, Marketbeat, Morningstar, Wallet Investor, Stockhouse, TradingView, GlobeNewswire, Dividend Investor, Technical420, Stockwatch, Seeking Alpha, Investorx, and Proactive Investors reported previously on CROP Infrastructure Corp. (CRXPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CROP Infrastructure Corp. concentrates on cannabis branding and real estate assets. The Company’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2115 acres of hemp CBD farms, and an increasing portfolio of common share equity in upcoming listings within the cannabis space. CROP Infrastructure lists on the OTC Markets. Incorporated in 2011, the Company is headquartered in Vancouver, British Columbia. It previously went by the name Fortify Resources, Inc. It changed its name to Crop Infrastructure Corp. in March of 2018.
CROP Infrastructure has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands. The Company works to take advantage of strategic capital investment in land expansion opportunities; assist with key big ticket investments, including greenhouses, foundations, roads, advanced hydroponics, electrical distribution networks, as well as specialized lighting systems.
Furthermore, CROP is working to develop relationships with approved agricultural plant input partners for uniformly safe fertilizers, nutrients, herbicides, and pesticides as an element of a bulk distribution service and unique GROWSAFE-CROPSAFE client certification program.
Last month, CROP Infrastructure announced that its Emerald Heights retail brand secured a provisional licence for a retail, delivery, and smoking lounge in Cathedral City, California, to vertically integrate its California brands. Moreover, CROP retained a local real estate broker to find suitable locations to set up its Emerald Heights flagship location. CROP’s subsidiary will be able to run delivery routes in the Bay Area, Coachella Valley, and is now seeking a Southern California distribution partner.
In addition, in June, CROP announced that its 30 percent owned DVG, LLC partner acquired additional facilities for a tenanted outdoor cannabis farm in Grant County, Washington. In return for acquiring the turnkey infrastructure and branding assets for DVG company, CROP is issuing 2,000,000 shares at a deemed price of $0.30 per share and has paid $46,000 USD cash. A Tier 3 licensed Tenant operates the farm and it is completely planted for the 2019 season.
Also, CROP announced recently that its investment holding, World Farms Corp., signed a definitive agreement with Graphite Energy Corp. to go public through a reverse takeover (RTO) on the Canadian Securities Exchange (CSE). Mr. Michael Yorke, CROP Chief Executive Officer, stated: “The RTO is proceeding as planned and is now subject to final approval by the CSE. By divesting our Italian and Jamaican assets to World Farms, it has allowed CROP to focus and expand its operations in the USA, as well as gain a major investment.”
Yesterday, CROP Infrastructure announced that Hempire increased its ownership of Flip Distro to 51 percent for $100,000 in capital expenditures (capex) and product marketing at the distribution company. Increasing the ownership in Flip Distro, in concert with the recently announced acquisition of the Cathedral City dispensary, lounge and California-wide delivery provisional licences, will enable the company to use Flip for a secondary fulfillment center for delivery logistics. CROP’s Humboldt Holdings has an option to acquire 100 percent of Hempire’s interest in Flip at any time it becomes legal and compliant to do so.
CROP Infrastructure Corp. (CRXPF), closed Thursday's trading session at $0.027, up 35%, on 7,000 volume with 1 trade. The average volume for the last 3 months is 6,064 and the stock's 52-week low/high is $0.008/$0.048999998.
Gungnir Resources, Inc. (ASWRF)
Junior Mining Network, Stock Scores, Mining Capital, Gold Stock Data, Proactive Investors, Wallmine, Canadian Insider, Stockhouse, InvestorsHub, Dividend Investor, Investors Hangout, TradingView, Northern Miner, and Wallet Investor reported earlier on Gungnir Resources, Inc. (ASWRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Gungnir Resources, Inc. is a mineral exploration company centered on discovery in mineral-rich Sweden. It holds gold and base metal exploration permits in Sweden’s prolific Vasterbotten District that hosts 12 million ounces of gold delineated in existing and mined resources plus a number of past-producing and producing volcanogenic massive sulphide (VMS) base metal mines. Gungnir Resources is based in Surrey, British and the Company lists on the OTC Markets.
Gungnir Resources’ key emphasis is the Knaften project positioned at the south end of the “Gold Line” (Knaften-Barsele Arc) that hosts several gold deposits. These include Faboliden and Svartliden (Dragon Mining), as well as the Barsele Gold-VMS project (Agnico Eagle). In 2017 and 2018, successful drill programs at Knaften resulted in back-to-back new base metal target discoveries; the Rodingtrask VMS and a Cu-Ni target located only 400 meters to the east. All three targets on Knaften are wide-open for expansion and further discovery.
In addition, Gungnir Resources holds an advance royalty from the sale of a gold project in British Columbia in 2014. It has received $3M so far from the project sale. $3M is still due to Gungnir in annual $1M payments. Furthermore, Gungnir holds permits encompassing two nickel deposits, Lappvattnet and Rormyrberget, that collectively host 70 million pounds of nickel in historical resources, and the recently staked Norrbotten gold and base metal permits in the Norrbotten District of Sweden.
This past April, Gungnir Resources reported that it entered into a royalty option agreement with Ximen Mining Corp. (XIM:TSX-V). It granted to Ximen an option to purchase the Company's remaining royalty interest in the Kenville Gold Mine property for total consideration of $1,700,000.
In May, Gungnir Resources reported that it has now, upon regulatory approval, received the $500,000 initial cash payment related to the sale of its remaining royalty interest in the Kenville Gold Mine property in British Columbia. In Sweden, drilling was scheduled to begin on June 3, 2019 on Gungnir’s new targets.
This royalty option agreement is between Gungnir Resources and Ximen Mining, Inc. whereby Ximen has the option to acquire the remaining interest in a 4 percent gross metal royalty over the Kenville Gold Mine property for $1,500,000 and 285,918 common shares of Ximen. The remaining consideration includes the share issuance and $1,000,000 in cash due to Gungnir on or before October 31, 2019.
Gungnir Resources has recently started drilling on its Knaften property in Sweden. The Company is initially focused on its Rodingtrask volcanogenic massive sulphide (VMS) target. Additionally, it plans to test the new copper-nickel target discovered by the Company in 2017 and extensions of the Knaften 300 Gold Zone, both on the Knaften property.
Gungnir Resources, Inc. (ASWRF), closed Thursday's trading session at $0.08335, even for the day, on 4,500 volume. The average volume for the last 3 months is 25,461 and the stock's 52-week low/high is $0.037399999/$0.292400002.
PASSUR Aerospace, Inc. (PSSR)
Zacks, Journal Transcript, Trading View, Investors Hangout, OTC Markets, Stockwatch, Marketbeat, The Street, Stockhouse, Wallet Investor, Market Screener, and Simply Wall St reported earlier on PASSUR Aerospace, Inc. (PSSR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
PASSUR Aerospace, Inc.’s mission is to improve worldwide air traffic efficiencies through connecting the globe’ aviation professionals onto a single aviation intelligence platform. The Company is an international leader in digital aviation operational excellence. PASSUR provides predictive analytics and decision support technology for the aviation industry, chiefly to improve the operational performance and cash flow of airlines and the airports where they operate. Established in 1967, PASSUR Aerospace has its corporate office in Stamford, Connecticut.
PASSUR’s information solutions are used at the five largest North American airlines, by more than 60 airport customers, and used at the top 30 North American airports, by greater than one hundred business aviation customers, and by the U.S. government. In addition, 53 percent of all U.S. domestic commercial flights are managed with PASSUR predictive analytics for predicted arrival times, by utilizing years of archived data, and real-time airspace analysis. This enables airlines and airports to always be ready for the aircraft.
The Company owns and operates the largest commercial passive radar network worldwide. It provides aircraft position updates every 1 to 4.6 seconds, powering a proprietary database that is accessible in real-time, and delivers timely and accurate information and solutions through PASSUR’s industry leading algorithms and business logic included in its products.
PASSUR maximizes airspace, runways, as well as gate usage, by using predictive analytics to determine how airports should be configured to get the most out of their capacity. The Company helps airlines, airports, and air traffic control prioritize departures to maximize capacity and minimize delays, by helping to ensure that all three stakeholders work together with the most accurate, timely information.
Recently, PASSUR Aerospace announced Revenues of $3,634,000 for the three months ended April 30, 2019, versus $3,502,000 for the same period in fiscal year 2018. This represents an increase of $132,000, or 4 percent. For the six months ended April 30, 2019, Revenues totaled $7,290,000, versus $7,015,000 for the same period in fiscal year 2018. This represents an increase of $275,000, or 4 percent.
Mr. Jim Barry, President and Chief Executive Officer of PASSUR Aerospace, said, "We are seeing positive results from our recent investments in comprehensive and automated solutions that deliver increased capacity to constrained airports and airspace systems and help meet the growing global demand for air travel."
PASSUR Aerospace, Inc. (PSSR), closed Thursday's trading session at $1.10, even for the day, on 1,075 volume. The average volume for the last 3 months is 622 and the stock's 52-week low/high is $1.04999995/$1.73000001.
Cardax, Inc. (CDXI)
Zacks, Street Insider, The Street, 4-Traders, Stockopedia, Morningstar, InvestorsHub, Market Exclusive, MarketWatch, GuruFocus, last10k, Barchart, Stockhouse, and Street Insider reported earlier on Cardax, Inc. (CDXI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cardax, Inc. is a development stage Life Sciences Company listed on the OTCQB. It dedicates primarily all its efforts to developing consumer health and pharmaceutical products that it believes will provide many of the anti-inflammatory benefits of steroids or NSAIDS through targeting many of the same inflammatory pathways and mediators, however with exceptional safety profiles. Cardax has its corporate headquarters in Honolulu, Hawaii.
The Company is preparing proprietary nature-identical products and related derivatives via total synthesis to provide scalable, pure, and economical therapies for diseases where inflammation and oxidative stress are strongly implicated. This includes, but is not limited to, osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate disease.
Cardax’s initial main focus is its astaxanthin technologies. Astaxanthin is a strong and safe, naturally occurring, anti-inflammatory and anti-oxidant without the adverse side effects characteristic of anti-inflammatory treatments using steroids or NSAIDS (including immune system suppression, liver damage, cardiovascular disease risk, and gastrointestinal bleeding).
The Company’s ZanthoSyn® is its first product to help consumers safely address their inflammatory health. Cardax says that ZanthoSyn® is a physician recommended, anti-inflammatory supplement for health and longevity that features astaxanthin with optimal absorption and purity. ZanthoSyn® contains astaxanthin, which is Generally Recognized as Safe (GRAS) according to Food and Drug Administration (FDA) regulations. The safety and efficacy of the Company’s product candidates have not been directly evaluated in clinical trials or confirmed by the FDA.
Cardax recently announced it launched its Cardiovascular Health Astaxanthin Supplement Evaluation (CHASE) clinical trial targeting cardiovascular inflammatory health. The first subject was dosed on September 19, 2018. This randomized, double-blind, placebo-controlled CHASE clinical trial will evaluate the effect of low-dose and high-dose ZanthoSyn® on cardiovascular health, as measured by C-Reactive Protein (CRP) levels, over 12 weeks in up to 360 subjects with documented cardiovascular risk factors. Additionally, the study will include an optional open label extension through 48 weeks.
In December 2018, Cardax and GNC announced that they are expanding the sales and marketing program for ZanthoSyn®. GNC is the exclusive brick-and-mortar retail channel for ZanthoSyn®. GNC will augment Cardax's sales and marketing efforts with additional initiatives to boost ZanthoSyn® product awareness and education among GNC store associates and customers nationwide.
Cardax, Inc. (CDXI), closed Thursday's trading session at $0.145, up 44.7106%, on 410,991 volume with 25 trades. The average volume for the last 3 months is 26,185 and the stock's 52-week low/high is $0.071999996/$0.239999994.
First Choice Healthcare Solutions, Inc. (FCHS)
007 Stock Chat, PennyStockSpy, Greenbackers, First Penny Picks, Marketbeat, Stocks Impossible, TheMicrocapNews, and OTCBB Journal reported previously on First Choice Healthcare Solutions, Inc. (FCHS), and today we report on the Company, here at the QualityStocks Daily Newsletter.
First Choice Healthcare Solutions, Inc. (FCHS) engages in owning and operating multi-specialty (non-physician-owned) medical centers of excellence throughout the southeastern United States. It is one of the nation's only non-physician-owned, publicly traded healthcare services companies centered on the delivery of complete musculoskeletal solutions with a concentration on Orthopaedic and Spine care. OTCQB-listed, FCHS is based in Melbourne, Florida.
The Company’s flagship integrated platform administers greater than 100,000 patient visits annually. The platform comprises First Choice Medical Group, The B.A.C.K. Center, and Crane Creek Surgery Center. FCHS medical centers of excellence focus on treating patients in various specialties. These include Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management, and also related diagnostic and ancillary services.
First Choice Medical Group (Melbourne, Florida) is the Company’s flagship multi-specialty medical center of excellence. First Choice Medical Group specializes in the delivery of musculoskeletal medicine and rehabilitative care with many quality-focused goals focused on enriching its patients’ care experience.
FCHS’s Crane Creek Surgery Center is an AAAHC accredited facility. Its dedication is to deliver premier, ambulatory surgical care in a convenient, comfortable outpatient environment. The 18,000-plus sq. ft. facility is in Melbourne, Florida within the Crane Creek Medical Center building. Moreover, this building is home to The B.A.C.K. Center. The B.A.C.K. Center is a leading, advanced orthopaedic spine and pain practice in Brevard County, Florida. FCHS has expanded its portfolio of Medical Centers of Excellence in the Florida Space Coast region with its Brevard Orthopaedic Spine & Pain Clinic, Inc. (d/b/a The B.A.C.K. Center).
Recently, FCHS announced the opening of its fifth therapy location in Brevard County, Florida. First Choice Physical Therapy’s newest location is at 4311 Norfolk Parkway, West Melbourne, Florida 32904. The modern 3,450 sq. ft. advanced treatment center includes three private exam rooms, the most up-to-date equipment to ensure evidenced based outcomes, and highly skilled therapists that center on a hands-on approach to patient care. The Company’s other locations are in Melbourne, Viera, Suntree and Indian Harbor Beach.
First Choice Healthcare Solutions, Inc. (FCHS), closed Thursday's trading session at $0.3213, up 24.5832%, on 33,913 volume with 18 trades. The average volume for the last 3 months is 15,574 and the stock's 52-week low/high is $0.155000001/$1.34000003.
RenovaCare, Inc. (RCAR)
NetworkNewsWire, Insider Financial, Zacks, Market Exclusive, The Biotech Investor, GuruFocus, BioPortfolio, Street Insider, The Street, StockInvest.us, Business Wire, Barchart, 4-Traders, Stockhouse, InvestorsHub, OTC Markets, Finance Registrar, Emerging Growth, Capital Cube, Advanced Equity Research, Wallet Investor, and MarketWatch reported earlier on RenovaCare, Inc. (RCAR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
RenovaCare, Inc. is developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its first product under development targets the body’s largest organ, the skin. RenovaCare is the developer of the patented CellMist™ and SkinGun™ technologies. These are for isolating and spraying a patient’s own stem cells onto burns and wounds for fast self-healing. RenovaCare is based in Pittsburgh, Pennsylvania.
The Company’s flagship technology, the CellMist™ System, uses its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. RenovaCare is developing its CellMist™ System as a promising new option for patients suffering from burns, chronic and acute wounds, and scars.
The CellMist™ System targets patients who suffer burns, chronic and acute wounds, acne scarring, and skin defects and diseases such as vitiligo. Based on preliminary case studies, CellMist™ System patients can be treated within 90 minutes of entering an emergency room. A patient’s stem cells are isolated, processed, and sprayed onto wound sites for quick healing.
In investigative clinical use in the U.S, SkinGun™ treatments have shown the potential to naturally and quickly heal burns and other serious wounds. The CellMist™ System harvests a patient’s stem cells from a small area of skin, usually around 1 square inch. It suspends them in the water-based CellMist™ Solution. The suspension is delicately sprayed onto the wound employing the SkinGun™ deposition device, where it starts to grow new skin at the cellular level.
Skin stem cells sprayed with the patented SkinGun™ device maintain 97.3 percent cell viability. There is no impairment to cell growth or metabolic activity when evaluated in vitro. RenovaCare has miniaturized the SkinGun™ from the size of a microwave to a device that fits comfortably in one hand.
Recently, RenovaCare announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Mr. Harmel S. Rayat, majority shareholder and Chairman of RenovaCare. This increases his family office’s total equity investment in RenovaCare since 2013 to more than $20 million. This investment round is assigned to advance RenovaCare’s regulatory approval process and clinical trial program. Mr. Rayat’s earlier investment rounds enabled pre-clinical development, product engineering, as well as intellectual property (IP) filings.
RenovaCare, Inc. (RCAR), closed Thursday's trading session at $1.48, up 34.5455%, on 85,005 volume with 135 trades. The average volume for the last 3 months is 11,645 and the stock's 52-week low/high is $0.949999988/$3.51999998.
New Jersey Mining Company (NJMC)
Equity Clock, 4-Traders, The Street, InvestorsHub, Zacks, SmallCapVoice, London Irvine Report, Plunkett Research, Marketbeat, and Market Screener reported earlier on New Jersey Mining Company (NJMC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
New Jersey Mining Company has constructed, and is the majority-owner and operator, of a fully-permitted, upgraded, 360-ton per day flotation mill and cyanide leach plant. It is also 100-percent owner of the Golden Chest Mine project. This is an historic lode gold producer that has been expanded, modernized, and operated by a first-class lessee. OTCQB-listed, New Jersey Mining is headquartered in Coeur d'Alene, Idaho. Its Mill office is in Kellogg, Idaho.
New Jersey Mining provides custom milling services for small-scale mining operations. The Company can offer, for larger companies, a variety of mining and exploration services, including custom milling. It is pursuing near-term production of its own, with a longer-term vision toward district-scale deposit potential.
New Jersey Mining is ramping up the flotation mill to handle incoming ore shipments from the nearby Golden Chest Mine. The Golden Chest Mine is now producing gold from open pit and underground operations. The flotation mill recycles process water. It uses a paste tailings disposal process patented by Company founder Mr. Fred Brackebusch to reduce impact on the environment. The New Jersey Mill can perform test and toll milling on material from mines and prospects within a wide radius of active mining camps in Montana, Idaho, and Washington.
In March 2018, New Jersey Mining announced that it added to its land holdings in North Idaho’s Murray Gold Belt (MGB) with the lease of the Four Square Property. The Four Square Property consists of 334 acres of mining claims, including 46 acres of patented mining claims, located near the town of Murray, three miles west of the Golden Chest Mine. Additionally, New Jersey Mining acquired, via staking, 348 additional acres of unpatented mining claims south of the leased area, next to the patented claims.
At the Golden Chest Mine, New Jersey Mining plans to drill through the winter and into the foreseeable future. The Company’s drill programs are centered on near-term and long-term evaluation, planning and development at the Golden Chest Mine. The addition of a second diamond drill is presently undergoing consideration.
New Jersey Mining Company (NJMC), closed Thursday's trading session at $0.195, up 30.00%, on 109,006 volume with 11 trades. The average volume for the last 3 months is 59,017 and the stock's 52-week low/high is $0.1105/$0.209900006.
Nutra Pharma Corp. (NPHC)
Serious Traders, PennyStocks24, StocksToBuyNow, Pumps and Dumps, Winston Small Cap, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, UndiscoveredEquities, Wallstreetlivechat, and Innovative Marketing reported earlier on Nutra Pharma Corp. (NPHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Nutra Pharma Corp. is a biotechnology company listed on the OTC Markets. The Company specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Nutra Pharma is marketing Nyloxin® and Pet Pain-Away™ in the Over-the-Counter (OTC) pain management market. Founded in 2000, Nutra Pharma is based in Coral Springs, Florida.
By way of its subsidiaries, the Company carries out basic drug discovery research and clinical development. The focus of its approach to drug discovery and the development of new therapeutic agents are based on specialized receptor-binding proteins found in nature, particularly those found in snake venom from the cobra.
Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN. Its MS drug RPI-78M was earlier granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. Nutra Pharma’s RPI-MN inhibits the entry of many viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).
Additionally, Nutra Pharma looks for strategic licensing partnerships to reduce the risks associated with the drug development process. The Company’s holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS.
Nutra Pharma’s Designer Diagnostics subsidiary engages in the research and development (R&D) of diagnostic test kits designed to be used for the quick identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).
Nutra Pharma offers several drug products for sale for pain treatment. One is Nyloxin®, the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The Company has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Another product is Nyloxin Extra Strength. This is the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Moreover, the Company has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.
In September 2018, Nutra Pharma announced that its work with EuroAmerican IP, LLC resulted in a listing of its Nyloxin® product line on the website, www.GoVets.com. GoVets is the online marketplace under the National Veteran Small Business Coalition (NVSBC) to buy from VA-verified Service-Disabled Veteran-Owned Small Businesses (SDVOSBs).
With growing concern regarding consumers using opioid and acetaminophen-based pain relievers, Nyloxin® offers an alternative, which does not rely on opiates or non-steroidal anti-inflammatory drugs, known as NSAIDs, for their pain relieving effects. Nyloxin® has a well-defined safety profile.
Nutra Pharma Corp. (NPHC), closed Thursday's trading session at $0.0002, even for the day, on 18,840,202 volume with 12 trades. The average volume for the last 3 months is 3,259,961 and the stock's 52-week low/high is $0.000099999/$0.001399999.
alpha-En Corp. (ALPE)
Amigo Bulls, Penny Stock Hub, Stockscores, Speculating Stocks, Penny Stock Tweets, Street Insider, OTC Markets, Business Insider, Real Pennies, InvestorsHub, GuruFocus, Barchart, MarketWatch, and Wall Street Mover reported on alpha-En Corp. (ALPE), and we also report on the Company, here at the QualityStocks Daily Newsletter.
alpha-En Corp. is a clean technology business based in Yonkers, New York. The Company concentrates on enabling next generation battery technologies through developing and bringing to market high purity lithium metal and associated products produced in an environmentally sustainable way. alpha-En lists on the OTC Market Group’s OTCQB.
Alpha-En’s lithium metal is purer than what is presently available on the market. It is free of all base metals and common non-conductive impurities found in the existing commercial supply. The Company enables next generation energy storage. Its focus is on room temperature production of high purity lithium metal and associated products. Furthermore, alpha-En’s flexible disposition method can streamline battery manufacturing, leading to battery production cost benefits.
The room temperature process requires minimal electricity. In addition, utilizing Lithium Carbonate as feedstock reduces the Company’s raw material costs. The process is conducted at 20°-30°C. The room temperature, proprietary, patent pending process is mercury and chlorine free. This eliminates the use and release of toxic chemicals and expensive containment costs. Alpha-En’s proprietary technology and the absence of numerous chemicals usually required yields an extremely pure product - lithium metal without nonconductive impurities.
alpha-En and Cornell University have entered into a cooperative agreement to conduct sponsored research at the Baker Laboratory, under the direction of Mr. Héctor D. Abruña. Cornell University's agreement is for conducting vital analysis related to quantifying capacity and ion transport for the process of lithium thin film production patented by alpha-En.
The expectation is that the collaboration will take advantage of the hi-tech facilities available at Cornell University, especially the ability to study thin films of lithium "in operando", meaning – making movies, at the microscopic scale, of lithium film growth, as it happens in real time.
Argonne National Laboratory has entered into a collaborative agreement with alpha-En to assist in the scale and optimization of the Company’s process. alpha-En is sponsoring R&D (Research & Development) at Princeton University lead by Daniel Steingart, Ph.D. Professor of Mechanical and Aerospace Engineering and the Andlinger Center for Energy and the Environment at Princeton.
alpha-En Corp. (ALPE), closed Thursday's trading session at $0.6389, up 25.2745%, on 9,750 volume with 12 trades. The average volume for the last 3 months is 13,477 and the stock's 52-week low/high is $0.159999996/$1.87999999.
Continental Energy Corp. (CPPXF)
TopPennyStockMovers, Streetwise Reports, and Agoracom reported previously on Continental Energy Corp. (CPPXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Continental Energy Corp. is an emerging developer of conventional and alternative energy capacity integrated with upstream and downstream petroleum supply within the Republic of Indonesia. Listed on the OTC Markets, the Company’s commitment is to developing hybrid renewable electrical power generation capacity and profitably operating mini-grid distribution networks in the huge, under-served markets of the fast-growing economies encircling the Indian Ocean Rim.
Established in 1984, Continental Energy is headquartered in Vancouver, British Columbia. The Company previously went by the name Continental Copper Corp. It changed its corporate name to Continental Energy Corp. in October of 1997.
The Company’s core competency exists in Indonesia. It has 30 years of experience in Indonesia. This has given Continental Energy the business relationships and local operating experience necessary to capitalize on the rising energy demand in this country.
In addition, Continental Energy has its business combination with the Ruaha River Power Company. This business combination provided instant entry into Tanzania. This is where the best-in-Africa commercial incentives for small scale renewable energy developers are in place to foster new supply of power to off-grid communities.
Recently, Continental Energy announced the filing on SEDAR of its audited consolidated financial statements and its management discussion and analysis for its Fiscal 2017 year ended June 30, 2017. Continental had a Loss from Operations of $439,606 during Fiscal 2017 versus a Loss from Operations of $473,289 during Fiscal 2016. This represents a decrease of $33,683, mainly because of lower professional fees and share-based payments.
The Company had a loss per share of $0.00 in both 2017 and 2016. Continental’s administrative costs were lower by $14,428 in 2017 versus 2016. This was chiefly because of reduced professional fees: 2017 - $376,842; and 2016 - $391,270. As at the end of this Fiscal Year 2017, Continental Energy’s Working Capital deficit was $1,721,256 versus a Working Capital deficit of $1,282,380 at the end of Fiscal 2016.
Continental Energy Corp. (CPPXF), closed Thursday's trading session at $0.027, up 35%, on 7,000 volume with 1 trade. The average volume for the last 3 months is 6,064 and the stock's 52-week low/high is $0.008/$0.048999998.
The QualityStocks Company Corner
- Hemptown USA
- Willow Biosciences Inc. (CSE: WLLW)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ)
- Geyser Brands Inc. (TSX.V: GYSR)
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- MustGrow Biologics Corp. (CSE: MGRO)
- Sharing Services Global Corporation (SHRG)
- City View Green Holdings Inc. (CSE: CVGR)
- Golden Developing Solutions, Inc. (DVLP)
The QualityStocks Daily Newsletter would like to spotlight Hemptown USA.
Hemptown USA, a privately held company headquartered in Southern Oregon’s Emerald Triangle, today announced the acquisition of all assets of Kirkman Group, a Lake Oswego, Oregon-based FDA licensed, current good manufacturing practice (“cGMP”) certified nutraceutical business. The acquisition includes the entirety of the management team, production equipment, formulations, proprietary intellectual property, current sales channels and fulfillment centers. This transaction also marks the company’s immediate entry into the consumer packaged goods space. “The Kirkman Group is a key strategic acquisition for Hemptown. Being fully operational and FDA licensed accelerates Hemptown’s vertical integrations plans. Kirkman’s high quality formulations and production standards will give Hemptown the best in-class products filling retail shelves,” Hemptown USA Chairman and Founder Rod Wolterman stated in the news release. To view the full press release, visit http://ibn.fm/RILth.
Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum hemp biomass grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company's "soil to oil" methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon's famed Emerald Triangle, Kentucky and Colorado.
Hemptown has exclusive rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. As a result of a long-standing relationship with the one of the world's most respected cannabis breeding companies – Oregon CBD Seeds – Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.
In 2018 Hemptown's harvest from its Oregon hemp farm was 150,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demands and projects it will reap over 1,000,000 pounds. By 2020, Hemptown projects potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.
By 2020, Hemptown anticipates it will have more than 3,000 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Development of business-to-business channels as well as new products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown's growth strategy.
Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing a proprietary water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.
Hemptown's first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company's original hemp farm in the Siskiyou Klamath region of Oregon. Sisku is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.
Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown's product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.
Company Chairman Rod Wolterman founded Hemptown's Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.
CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent's first GMP and ISO-accredited cultivation and manufacturing facility.
Dr. Gordon Chiu is chief science officer for Hemptown USA. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master's degree from Seton Hall University, Chiu is leading Hemptown's cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.
- Hemptown USA Enters Consumer Packaged Goods Space through Kirkman Group Acquisition
- The Cannabinoid of the Future? Hemptown USA at the Forefront of CBG’s Rise to Prominence
- QualityStocksNewsBreaks – Hemptown USA Positioned as Leading Producer of CBG — Potential Next Big Thing
Willow Biosciences Inc. (CSE: WLLW)
Willow Biosciences Inc. (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (APIs) and intermediates, is pursuing the burgeoning CBD market with a world-class partner. Willow recently announced a joint development agreement (JDA) with Noramco Inc., a leading manufacturer of cannabinoids, to collaboratively develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (CBD) (http://nnw.fm/8YcLU).
Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.
The company is headquartered in Calgary, Alberta, Canada.
Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.
The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.
Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.
Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.
Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.
The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.
Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.
The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.
The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.
The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.
Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.
President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.
Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.
Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.
Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.
Willow Biosciences Inc. (CSE: WLLW), closed Thursday's trading session at $0.88, up 3.53%, on 552,871 volume with 101 trades. The average volume for the last 3 months is 51,522 and the stock's 52-week low/high is $0.76999998/$5.25.
- Willow Biosciences Inc. (CSE: WLLW) Developing Biosynthesis Platform for Production of Low-Cost, Pharmaceutical-Grade CBD
- Willow Biosciences Inc. (CSE: WLLW) is “One to Watch”
- Video Outlines Benefits of Willow Biosciences Inc.’s (CSE: WLLW) JDA to Develop CBD through Biosynthesis
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to Universal Hemp LLC. Under the agreement, Universal Hemp, a B2B manufacturer of high-performing hemp-derived bulk ingredients to the consumer packaged goods and nutraceutical industries, will utilize the technology in many CBD-based food ingredients to be produced and sold across the U.S. immediately, as well as in Canada when regulations permit. To view the full press release, visit: http://nnw.fm/Ju1bm.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.
In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.8633, up 4.8139%, on 147,741 volume with 121 trades. The average volume for the last 3 months is 86,617 and the stock's 52-week low/high is $0.75/$2.24.
- Lexaria Bioscience Corp.’s (CSE: LXX) (OTC: LXRP) DehydraTECH to be Leveraged Through CBD License Agreement with Universal Hemp
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters CBD Beverage License Agreement with Nic's Beverages
- Lexaria Bioscience Corp to Webcast Live at VirtualInvestorConferences.com July 11th
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Automotive technology innovator Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., will conduct a large-scale trial of its Eye-Net(TM) cellular-based accident prevention solution for the first time. To view the full press release, visit: http://nnw.fm/3asBO.
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.
Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.
The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.
Foresight has developed three main products:
- QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
- Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
- Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.
In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.
Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.
Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.
Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.
Foresight Autonomous Holdings Ltd. (FRSX), closed Thursday's trading session at $1.98, up 6.4516%, on 2,891,464 volume with 6,580 trades. The average volume for the last 3 months is 467,085 and the stock's 52-week low/high is $0.697000026/$3.42269992.
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Subsidiary to Conduct Five Day Trial of Cellular-Based Accident Prevention Solution
- Foresight Successfully Completes Technological Demonstrations for Leading Vehicle Manufacturers and Tier One Suppliers in United States
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Multi-Phase Agreement with Chinese Tier One Automotive Supplier
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Oil and gas industry technology innovator Petroteq Energy (TSX.V: PQE) (OTC: PQEFF) recently posted a video tour of its Utah extraction facility to describe the technology’s processes and potential. To view the full article, visit: http://nnw.fm/I3T4l.
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PQEFF), closed Thursday's trading session at $0.2154, up 7.70%, on 246,785 volume with 64 trades. The average volume for the last 3 months is 263,640 and the stock's 52-week low/high is $0.194999992/$1.42999994.
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Explains Innovative Heavy-Oil Recovery Process in Video Tour of Extraction Facility
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Secures Licensing Contract for its CORT Oil Extraction Technology
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Enters Technology Licensing Agreement with Valkor LLC
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)
QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) was featured today in a publication from NetworkNewsWire. Global lithium demand is anticipated to triple by 2025, driven primarily by expanded lithium-ion battery production for the electric vehicle market. According to a lithium market update, demand for lithium grew by more than 27 percent in 2018 (http://nnw.fm/94uXb) and is expected to grow at rates above 20 percent in 2019.
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.
QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.
The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.
North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.
The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.
QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens, and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.
The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.
QMC Quantum Minerals Corp. (QMCQF), closed Thursday's trading session at $0.14, up 9.8901%, on 22,407 volume with 6 trades. The average volume for the last 3 months is 50,554 and the stock's 52-week low/high is $0.115500003/$0.319999992.
- QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) Developing Key Resource Portfolio as Lithium Demand Rises
- QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) Evaluating Further Pegmatite Dikes at Irgon Project
- NetworkNewsBreaks – QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) Confirms Significant Spodumene Mineralization on Irgon Property
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands Inc. (TSX.V: GYSR), a leading consumer health care company based in Vancouver, British Columbia, builds health-based hemp CBD consumer products in the worldwide nutraceutical, cosmetics, food & beverage and pet sectors. Recent pivotal appointments to Geyser Brand’s leadership team are expected to strengthen the company’s position and bring valued oversight to its ongoing development, as noted in a news release (http://nnw.fm/0VyV1). Also today, NetworkNewsWire released a report on the company detailing how wholly owned subsidiary, Apothecary Botanicals, recently achieved a major milestone when it received its standard processing license, enabling Geyser to advance its brands (http://nnw.fm/Jj87Q ). To view the full article, visit: http://nnw.fm/uLdP6 .
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Thursday's trading session at $0.55, even for the day, on 2,000 volume. The average volume for the last 3 months is 8,461 and the stock's 52-week low/high is $0.33/$0.85.
- Geyser Brands Inc. (TSX.V: GYSR) Strengthens Leadership with Key Appointments
- Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Secures Coveted Standard Processing License
- Geyser Brands Inc. (TSX.V: GYSR) Reaches Milestone in CBD Wellness Market with Reception of Processing License
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) was featured today in a report from FN Media Group as a trusted industry producer set to be a forerunner in the cannabis products market. When the United Kingdom’s National Health Service (NHS) made cannabidiols (CBD) legal for medical use in November 2018, the health and wellness applications put in place for the benefit of British consumers seemed nearly boundless. With the rapid growth of the CBD product market, it’s becoming more and more important that consumers avoid poor quality products from unregulated, and often unreputable, sources.
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $6.28, off by 5.279%, on 1,798,426 volume with 6,347 trades. The average volume for the last 3 months is 978,928 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- Toxic, Low-Quality CBD Products Putting Consumers at Risk
- Organigram and Lift & Co. Enhance Education of Cannabis Frontline Staff via Brand-Specific Training Program
- The Six Stars Of The Cannabis Industry In 2019
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) and Blissco Cannabis Corp. ("Blissco") (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B:GR) are pleased to announce that the Supreme Court of British Columbia has issued a final order (the "Final Order") approving the previously announced plan of arrangement (the "Arrangement") between Supreme Cannabis and Blissco. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how, not too long ago, cannabis was just the feel-good supplement of choice for a young generation, looking to blow off steam. But intense research on the plant has led to new discoveries. Today, cannabis is used not only to blow off some steam, but to treat diseases which effect the immune system, pain and inflammation, seizures and even mental disorders.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $1.055, off by 3.21%, on 525,182 volume with 529 trades. The average volume for the last 3 months is 316,503 and the stock's 52-week low/high is $39.50/$75.9899978.
- Supreme Cannabis to Close Acquisition of Premium Wellness Brand and Extraction Company Blissco
- The Most Important Cannabis Trends Of 2019
- CBD Companies Quickly Expanding their Global Footprint
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Vancouver-based cannabis company Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) has been diligently working on a strategic initiative to expand its product offerings. A recent article discussing the company reads, “In March 2019, the company announced that it was expanding its offerings through the introduction of Pure and Pure Plus tinctures. To view the full article, visit: http://nnw.fm/QD4mB.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Thursday's trading session at $0.451, off by 0.132861%, on 500 volume with 2 trades. The average volume for the last 3 months is 20,385 and the stock's 52-week low/high is $0.009999999/$1.12999999.
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Focuses on Expanding Suite of CBD, Hemp-Derived Products
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Consumer Access with Retail Partnerships for CBD Product Lines
- Buzzfeed.com Features Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) Disposable Vaporizers, Aches and Immunity
MustGrow Biologics Corp. (CSE: MGRO)
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
MustGrow Biologics Corp. (CSE: MGRO) (“MustGrow” or the "Company"), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, is pleased to announce that a biopesticide R&D program is underway with the National Research Council Canada (“NRC”). Also today, NetworkNewsWire released a report on the company detailing how as the global organic farming market continues growing at a sustainable and consistent rate, new expansion opportunities emerge for organizations such as MGRO, an agricultural biotech company that develops and commercializes natural biopesticides and bio-fertilizers serving as an alternative to synthetic pesticides and fertilizers typically used by cannabis and fruit and vegetable growers.
MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients?(http://nnw.fm/Qkz21).?For the past 50 years,?nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
MustGrow Biologics Corp. (CSE: MGRO), closed Thursday's trading session at $0.275, off by 14.06%, on 289,652 volume with 93 trades. The stock's 52-week low/high is $0.275000005/$0.699999988.
- MustGrow Biologics Corp. (CSE: MGRO) Announces Cannabis Biopesticide R&D Program with a Canadian Federal Research Organization
- Growth of Organic Farming Providing Opportunities for Natural Biopesticide Companies Like MustGrow Biologics Corp. (CSE: MGRO)
- MustGrow Biologics Corp. (CSE: MGRO), a Provider of Natural Biopesticides and Biofertilizers to the Cannabis Industry, Commences CSE Trading Today
Sharing Services Global Corporation (SHRG)
Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., today announced revenues of $85.9 million for the fiscal year ended April 2019, which represents a ninefold increase of approximately $77.5 million compared to $8.4 million fiscal year 2018 revenues. To view the full press release, visit: http://nnw.fm/zJV0u.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.17, off by 10.3848%, on 18,772 volume with 5 trades. The average volume for the last 3 months is 19,799 and the stock's 52-week low/high is $0.1026/$0.3944.
- Sharing Services Inc. (SHRG) Reports Ninefold Increase in FY2019 Revenues, Continues Record Trend
- Sharing Services Inc.’s (SHRG) Business Entrepreneurship Model Drives Success in Booming Direct-Sales Market
- Sharing Services Global Corporation (SHRG) Positioned for Direct-Selling Growth in Canada, International Markets; Pursuing Nasdaq Uplisting
City View Green Holdings Inc. (CSE: CVGR)
City View Green Holdings Inc. (CSE: CVGR), a vertically integrated cannabis company, recently announced an exciting development occurring with retail partner Budd Hutt. The latter has entered into an agreement to significantly expand its footprint in the Canadian retail cannabis marketplace. Budd Hutt owns a 19.9 percent stake in City View. NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://nnw.fm/CVGR
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Thursday's trading session at $1.135, off by 3.57%, on 9,500 volume with 3 trades. The average volume for the last 3 months is 149,582 and the stock's 52-week low/high is $0.094999998/$0.465000003.
- City View Green Holdings Inc.’s (CSE: CVGR) Partner Announces Substantial Retail Expansion in Alberta Cannabis Marketplace
- City View Green Holdings Inc.’s (CSE: CVGR) Retail Arm Pursuing Retail Cannabis Partnerships
- City View Green Announces Proposed $3,000,000 Private Placement
Golden Developing Solutions, Inc. (DVLP)
Golden Developing Solutions Inc. (OTC:DVLP) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “Cannabis Companies Seek Strong Strategies to Meet Growing Demand,” please visit: http://cnw.fm/1cT4M.
Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.
Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.
DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.
DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.
WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.
“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”
The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.
“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”
Golden Developing Solutions, Inc. (DVLP), closed Thursday's trading session at $0.0113, off by 8.4279%, on 1,043,165 volume with 60 trades. The average volume for the last 3 months is 3,281,177 and the stock's 52-week low/high is $0.0102/$0.14.
- Golden Developing Solutions Featured in CannabisNewsWire Publication Discussing Smart Strategies, Strong Revenues
- Golden Developing Solutions Inc. (DVLP) Cannabis Companies Seek Strong Strategies to Meet Growing Demand
- Golden Developing Solutions Inc. (DVLP) Achieves Fully Reporting Status with SEC
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) in Final Negotiations to Significantly Expand Cannabis Cultivation and Retail Operations
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Portfolio Company’s Receipt of Five New AGLC Cannabis Retail Licenses
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – Colorado Governor Unveils Online Tool to Track Cannabis Achievements
- ChineseInvestors.com (CIIX) After Growth in CBD Sector, CIIX Resumes Financial Consultancy Services for Chinese Community in the US
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Surpasses $49,000 in Opening Day Sales at the Niagara Flagship Cannabis Store
- City View Green Holdings Inc. (CSE: CVGR) Retail Arm Pursuing Retail Cannabis Partnerships
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Subsidiary Advancing Women’s Wellbeing
- Endonovo Therapeutics (OTCQB: ENDV) Adds National Leader to Scientific Advisory Board
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Successfully Completes Technological Demonstrations for Leading Vehicle Manufacturers and Tier One Suppliers in United States
- Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
- Geyser Brands Inc. (TSX.V: GYSR) Reaches Milestone in CBD Wellness Market with Reception of Processing License
- Golden Developing Solutions, Inc. (DVLP) Cannabis Companies Seek Strong Strategies to Meet Growing Demand
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) to Create First '360 Degree' Cannabis Company Through a Combination with MXY Holdings LLC
- Green Hygienics Holdings Inc. (GRYN) Obtains Lucrative, Multiyear Hemp Purchase Order
- Hemptown USA - The Cannabinoid of the Future? Hemptown USA at the Forefront of CBG’s Rise to Prominence
- INmune Bio, Inc. (NASDAQ: INMB) Co-Founder and CEO Showcases XPro1595 at Maxim Group’s Conference on Alzheimer’s Disease
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Enters Agreement with Lifespot to Develop and Distribute Software and Vaporizer Technologies
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Enters CBD Beverage License Agreement with Nic's Beverages
- Marijuana Company of America Inc. (MCOA) Announces Reverse Stock Split of Common Stock
- MustGrow Biologics Corp. (CSE: MGRO) a Provider of Natural Biopesticides and Biofertilizers to the Cannabis Industry, Commences CSE Trading Today
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) 420 with CNW – Teen Marijuana Use Reduces When Recreational Use Laws Are Passed, Study Finds
- Net Element, Inc. (NASDAQ: NETE) 420 with CNW – Teen Marijuana Use Reduces When Recreational Use Laws Are Passed, Study Finds
- Nightfood, Inc. (OTCQB: NGTF) Beyond Food-Organic and Healthier Food Trends 2019
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) and Lift & Co. Enhance Education of Cannabis Frontline Staff via Brand-Specific Training Program
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Phase 2 Nickel-Cobalt Extraction Process Testing and Evaluation Commences
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Secures Licensing Contract for its CORT Oil Extraction Technology 6
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Dominates California Edibles Market
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at Spectrometry Conference
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Assay Results Suggest Further Tonnage at Irgon Property
- Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) Client Wahupta Signs First USA-Based Customer
- Sharing Services Global Corporation (SHRG) Business Entrepreneurship Model Drives Success in Booming Direct-Sales Market
- SinglePoint, Inc. (SING) CBD/Hemp Snapshot: Growing Demand is Game Changer for Sector - Driving Revenues and Acquisitions
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Optimizes Communications with Dedicated In-Vehicle UV350 Smartphone
- Spectrum Global Solutions, Inc. (SGSI) Announces Decision to Terminate Definitive Share Purchase Agreement with WaveTech Global
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Releases Financial Results, Announces Strategic Accomplishments for Fiscal 2019
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Breaks Ground for Its Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Focuses on Next-Generation Extraction Tech to Prepare Hemp Sector for Expected Crop Boom
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) CBD Companies Quickly Expanding their Global Footprint
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) The Must-Know Cannabis Stocks before Vapes Hit Canadian Shelves in December 2019
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Enters Definitive Agreement to Acquire The GoodFellas Group LLC
- Trxade Group Inc. (TRXD) Web Platform Promises Reduced Negative Reimbursement Costs for Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Cannabis Edibles Could Cause a Spike in Life Insurance Premiums for Canadians
- VPR Brands, LP (VPRB) Bolsters Presence as Global Leader in Cannabis Vaporizer Products
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Consumer Access with Retail Partnerships for CBD Product Lines
- Willow Biosciences Inc. (CSE: WLLW) Is ‘One to Watch’
- Youngevity International, Inc. (NASDAQ: YGYI) Horizons ETFs Rebalances Marijuana-Focused ETFs
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.